BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38583808)

  • 21. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the simian varicella virus glycoprotein E.
    Gray WL; Mullis LB; Soike KF
    Virus Res; 2001 Nov; 79(1-2):27-37. PubMed ID: 11551643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates.
    Hong SH; Oh H; Park YW; Kwak HW; Oh EY; Park HJ; Kang KW; Kim G; Koo BS; Hwang EH; Baek SH; Park HJ; Lee YS; Bang YJ; Kim JY; Bae SH; Lee SJ; Seo KW; Kim H; Kwon T; Kim JH; Lee S; Kim E; Kim Y; Park JH; Park SI; Gonçalves M; Weon BM; Jeong H; Nam KT; Hwang KA; Kim J; Kim H; Lee SM; Hong JJ; Nam JH
    Sci Adv; 2021 May; 7(22):. PubMed ID: 34049881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Array analysis of simian varicella virus gene transcription in productively infected cells in tissue culture.
    Deitch SB; Gilden DH; Wellish M; Smith J; Cohrs RJ; Mahalingam R
    J Virol; 2005 May; 79(9):5315-25. PubMed ID: 15827146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.
    Hsieh PK; Chang SC; Huang CC; Lee TT; Hsiao CW; Kou YH; Chen IY; Chang CK; Huang TH; Chang MF
    J Virol; 2005 Nov; 79(22):13848-55. PubMed ID: 16254320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DNA sequence of the simian varicella virus genome.
    Gray WL; Starnes B; White MW; Mahalingam R
    Virology; 2001 May; 284(1):123-30. PubMed ID: 11352673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial artificial chromosome derived simian varicella virus is pathogenic in vivo.
    Meyer C; Dewane J; Haberthur K; Engelmann F; Arnold N; Gray W; Messaoudi I
    Virol J; 2013 Sep; 10():278. PubMed ID: 24010815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the simian varicella virus glycoprotein L and H.
    Ashburn CV; Gray WL
    Arch Virol; 2002; 147(2):335-48. PubMed ID: 11890527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simian Varicella Virus Infects Enteric Neurons and α4β7 Integrin-Expressing Gut-Tropic T-Cells in Nonhuman Primates.
    Ouwendijk WJD; van Veen S; Mehraban T; Mahalingam R; Verjans GMGM
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29597335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
    Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ
    Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).
    Suresh MR; Bhatnagar PK; Das D
    J Pharm Pharm Sci; 2008 Apr; 11(2):1s-13s. PubMed ID: 19203466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.
    Xiao K; Zhai J; Feng Y; Zhou N; Zhang X; Zou JJ; Li N; Guo Y; Li X; Shen X; Zhang Z; Shu F; Huang W; Li Y; Zhang Z; Chen RA; Wu YJ; Peng SM; Huang M; Xie WJ; Cai QH; Hou FH; Chen W; Xiao L; Shen Y
    Nature; 2020 Jul; 583(7815):286-289. PubMed ID: 32380510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
    van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
    J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
    Chen J; Miao L; Li JM; Li YY; Zhu QY; Zhou CL; Fang HQ; Chen HP
    World J Gastroenterol; 2005 Oct; 11(39):6159-64. PubMed ID: 16273643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.
    Traina-Dorge V; Pahar B; Marx P; Kissinger P; Montefiori D; Ou Y; Gray WL
    Vaccine; 2010 Sep; 28(39):6483-90. PubMed ID: 20654666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.